Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Chubb
Express Scripts
Daiichi Sankyo
QuintilesIMS
McKesson
Cerilliant
Boehringer Ingelheim
US Army

Generated: January 16, 2018

DrugPatentWatch Database Preview

Warner Chilcott Company Profile

« Back to Dashboard

What is the competitive landscape for WARNER CHILCOTT, and what generic alternatives to WARNER CHILCOTT drugs are available?

WARNER CHILCOTT has eighty-four approved drugs.

There are five US patents protecting WARNER CHILCOTT drugs and there have been two Paragraph IV challenges on WARNER CHILCOTT drugs in the past three years.

There are one hundred and twenty patent family members on WARNER CHILCOTT drugs in forty-four countries and fifty-three supplementary protection certificates in eleven countries.

Summary for Warner Chilcott
International Patents:120
US Patents:5
Tradenames:42
Ingredients:39
NDAs:84

Drugs and US Patents for Warner Chilcott

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Warner Chilcott QUINIDINE SULFATE quinidine sulfate TABLET;ORAL 083879-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Warner Chilcott CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 072139-001 Jun 13, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Warner Chilcott DIAZEPAM diazepam TABLET;ORAL 070209-001 Sep 4, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Warner Chilcott CYCLOPAR tetracycline hydrochloride CAPSULE;ORAL 062332-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Warner Chilcott FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 071767-001 Dec 4, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Warner Chilcott FUROSEMIDE furosemide TABLET;ORAL 018419-002 Jan 31, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Warner Chilcott AMITRIL amitriptyline hydrochloride TABLET;ORAL 083939-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Warner Chilcott HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 087586-001 May 3, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Warner Chilcott PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 070438-001 Sep 15, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Warner Chilcott CYCLOPAR tetracycline hydrochloride CAPSULE;ORAL 062332-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Warner Chilcott

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Warner Chilcott ACTONEL WITH CALCIUM (COPACKAGED) calcium carbonate; risedronate sodium TABLET, TABLET;ORAL 021823-001 Aug 12, 2005 ➤ Subscribe ➤ Subscribe
Warner Chilcott ACTONEL WITH CALCIUM (COPACKAGED) calcium carbonate; risedronate sodium TABLET, TABLET;ORAL 021823-001 Aug 12, 2005 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for WARNER CHILCOTT drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 50 mg ➤ Subscribe 11/5/2015
➤ Subscribe Delayed-release Tablets 80 mg ➤ Subscribe 7/1/2015
➤ Subscribe Delayed-release Tablets 200 mg ➤ Subscribe 5/19/2014
➤ Subscribe Delayed-release Tablets 200 mg ➤ Subscribe 8/12/2013
➤ Subscribe Delayed-release Tablets 150 mg ➤ Subscribe 12/19/2008

Non-Orange Book US Patents for Warner Chilcott

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,225,294 Method for inhibiting bone resorption ➤ Subscribe
6,333,316 Method for inhibiting bone resorption ➤ Subscribe
6,544,967 Method for inhibiting bone resorption ➤ Subscribe
6,569,460 Film-coated tablet for improved upper gastrointestinal tract safety ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Warner Chilcott Drugs

Supplementary Protection Certificates for Warner Chilcott Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1999 Austria ➤ Subscribe PRODUCT NAME: FOSPHENYTOIN-NATRIUM; NAT. REGISTRATION NO/DATE: 1-22664 19980728; FIRST REGISTRATION: GB 00019/0157 19980204
2006002 Lithuania ➤ Subscribe PRODUCT NAME: NATRIUM ALENDRONICUM/COLECACIFEROLUM; REGISTRATION NO/DATE: EU/1/05/310/001, EU/1/05/310/002, EU/1/05/310/003, EU/1/05/310/004, EU/1/05/310/005 20050824
/2015 Austria ➤ Subscribe PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211
0443983/03 Switzerland ➤ Subscribe PRODUCT NAME: VALSARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE; REGISTRATION NUMBER/DATE: SWISSMEDIC 59407 16.09.2009
156 Luxembourg ➤ Subscribe PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211
00125 Netherlands ➤ Subscribe PRODUCT NAME: ROSUVASTATINUM, DESGEWENST IN DE VORM VAN EEN NIET-TOXISCH FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET CALCIUMZOUT; REGISTRATION NO/DATE: RVG 26872 - RVG 26874 20021106
2008006 Lithuania ➤ Subscribe PRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712
2007 00045 Denmark ➤ Subscribe
C0005 Belgium ➤ Subscribe PRODUCT NAME: FOSPHENYTOIN DISODIUM; NAT. REGISTRATION NO/DATE: NL 23 613 19980806; FIRST REGISTRATION: GB - PL 000 19/0157 19980204
C/GB99/008 United Kingdom ➤ Subscribe PRODUCT NAME: 2-N-BUTYL-4-SPIROCYCLOPENTANE-1-((2'-(TETRAZOL-5-YL)BIPHENYL-4-YL)METHYL)-2-IMIDAZOLIN-5-ONE)(GENERIC NAME IRBESARTAN) OPTIONALLY IN THE FORM OF ONE OF ITS SALTS AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/98/086/001 19981015; UK EU/1/98/086/002 19981015; UK EU/1/98/086/003 19981015; UK EU/1/98/086/004 19981015; UK EU/1/98/086/005 19981015; UK EU/1/98/086/006 19981015
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Medtronic
Farmers Insurance
Mallinckrodt
Deloitte
AstraZeneca
Healthtrust
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot